Concepedia

Liraglutide, a GLP-1 receptor agonist, inhibits vascular smooth muscle cell proliferation by enhancing AMP-activated protein kinase and cell cycle regulation, and delays atherosclerosis in ApoE deficient mice

Teruo Jojima, Kohsuke Uchida, Kazumi Akimoto, Takanori Tomotsune, Kazunori Yanagi, Toshie Iijima, Kunihiro Suzuki, Kikuo Kasai, Yoshimasa Aso

Atherosclerosis · 2017 · 102 citations · 21 references

References

21

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

Steven P. Marso, Gilbert H. Daniels, Kirstine Brown‐Frandsen et al. · New England Journal of Medicine · 2016 · 7.3K citations · Full text

Medicine, Endocrinology, Pharmacotherapy +13

Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis

Murray C.H. Clarke, Nichola Figg, Janet J. Maguire et al. · Nature Medicine · 2006 · 644 citations

Life Sciences, Cardiology, Cell Biology +14

Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4

Masayuki Arakawa, Tomoya Mita, Kosuke Azuma et al. · Diabetes · 2010 · 536 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men

Henrik Agersø, Lene Jensen, B. Elbrønd et al. · Diabetologia · 2002 · 506 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +9

Restenosis After Experimental Angioplasty

Antoine Lafont, Luis A. Guzmán, Patrick L. Whitlow et al. · Circulation Research · 1995 · 312 citations

Medicine, Cardiology, Clinical Cardiology +11